tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRBP Stock Latest News

Corbus Pharmaceuticals files $300M mixed securities shelf
The FlyCorbus Pharmaceuticals files $300M mixed securities shelf
12d ago
CRBP
Corbus Pharmaceuticals price target raised to $57 from $53 at Oppenheimer
PremiumThe Fly
Corbus Pharmaceuticals price target raised to $57 from $53 at Oppenheimer
13d ago
CRBP
Corbus Pharmaceuticals: Advancing Best-in-Class Nectin-4 ADC and Emerging Obesity Franchise Support Buy Rating
PremiumRatings
Corbus Pharmaceuticals: Advancing Best-in-Class Nectin-4 ADC and Emerging Obesity Franchise Support Buy Rating
14d ago
CRBP
Corbus: Buy Rating Backed by CRB-701 Oncology Potential, Obesity Pipeline Catalysts, and Cash Runway Into 2028
PremiumRatings
Corbus: Buy Rating Backed by CRB-701 Oncology Potential, Obesity Pipeline Catalysts, and Cash Runway Into 2028
14d ago
CRBP
Corbus Pharmaceuticals Highlights 2025 Results and Pipeline Progress
PremiumCompany Announcements
Corbus Pharmaceuticals Highlights 2025 Results and Pipeline Progress
14d ago
8K
CRBP
Corbus Pharmaceuticals reports Q4 EPS ($1.25), consensus ($1.58)
PremiumThe FlyCorbus Pharmaceuticals reports Q4 EPS ($1.25), consensus ($1.58)
14d ago
CRBP
Corbus Highlights Diversified Oncology and Metabolic Pipeline Outlook
Premium
Company Announcements
Corbus Highlights Diversified Oncology and Metabolic Pipeline Outlook
26d ago
8K
CRBP
Corbus Advances Early-Stage Obesity Drug CRB-913: What Investors Should Watch Now
Premium
Company Announcements
Corbus Advances Early-Stage Obesity Drug CRB-913: What Investors Should Watch Now
2M ago
CRBP
Corbus Updates Corporate Outlook, Highlights Diversified 2026 Pipeline
PremiumCompany Announcements
Corbus Updates Corporate Outlook, Highlights Diversified 2026 Pipeline
2M ago
8K
CRBP
Corbus Pharmaceuticals Announces Retirement of Board Member Holmer
PremiumCompany Announcements
Corbus Pharmaceuticals Announces Retirement of Board Member Holmer
3M ago
8K
CRBP
Promising Initial Results and Strong Safety Profile Bolster Buy Rating for Corbus Pharmaceuticals’ CRB-913
PremiumRatings
Promising Initial Results and Strong Safety Profile Bolster Buy Rating for Corbus Pharmaceuticals’ CRB-913
3M ago
CRBP
Optimistic Buy Rating for Corbus Pharmaceuticals: Promising Phase 1 Results for CRB-913 in Obesity Treatment
PremiumRatings
Optimistic Buy Rating for Corbus Pharmaceuticals: Promising Phase 1 Results for CRB-913 in Obesity Treatment
3M ago
CRBP
Buy Rating for Corbus Pharmaceuticals Driven by Promising CRB-913 Developments and Market Potential
PremiumRatingsBuy Rating for Corbus Pharmaceuticals Driven by Promising CRB-913 Developments and Market Potential
3M ago
CRBP
RBC Capital says Corbus undervalued as ‘913 shows hints of weight loss
Premium
The Fly
RBC Capital says Corbus undervalued as ‘913 shows hints of weight loss
3M ago
CRBP
Morning Movers: Oracle continues to slide despite earnings beat
Premium
The Fly
Morning Movers: Oracle continues to slide despite earnings beat
3M ago
LLY
OXM
Corbus Pharmaceuticals Advances Obesity Treatment with CRB-913
PremiumCompany Announcements
Corbus Pharmaceuticals Advances Obesity Treatment with CRB-913
3M ago
8K
CRBP
Corbus Pharmaceuticals reports results from Phase 1a study of CRB-913 in obesity
PremiumThe Fly
Corbus Pharmaceuticals reports results from Phase 1a study of CRB-913 in obesity
3M ago
CRBP
Corbus Pharmaceuticals price target lowered to $53 from $55 at RBC Capital
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $53 from $55 at RBC Capital
4M ago
CRBP
Corbus Pharmaceuticals: Promising Pipeline and Strategic Plans Justify Buy Rating
PremiumRatings
Corbus Pharmaceuticals: Promising Pipeline and Strategic Plans Justify Buy Rating
4M ago
CRBP
Corbus Pharmaceuticals Advances Oncology and Obesity Pipeline
PremiumCompany AnnouncementsCorbus Pharmaceuticals Advances Oncology and Obesity Pipeline
4M ago
CRBP
Corbus Pharmaceuticals: Strong Financials and Promising Clinical Pipeline Drive Buy Rating
Premium
Ratings
Corbus Pharmaceuticals: Strong Financials and Promising Clinical Pipeline Drive Buy Rating
4M ago
CRBP
Corbus Pharmaceuticals Completes $75 Million Public Offering
Premium
Company Announcements
Corbus Pharmaceuticals Completes $75 Million Public Offering
4M ago
8K
CRBP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >